{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T13:11:09Z","timestamp":1792933869305,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1208\/s12249-020-1626-2","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T16:05:04Z","timestamp":1580745904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Effect of Formulation Variables and Gamma Sterilization on Transcorneal Permeation and Stability of Proniosomal Gels as Ocular Platforms for Antiglaucomal Drug"],"prefix":"10.1208","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-9105","authenticated-orcid":false,"given":"Sinar","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Abdelmoteleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia M.","family":"Khowessah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"1626_CR1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.4.4.371","volume":"4","author":"KG Janoria","year":"2007","unstructured":"Janoria KG, Gunda S, Boddu SH, Mitra AK. Novel approaches to retinal drug delivery. Expert Opin Drug Deliv. 2007;4:371\u201388.","journal-title":"Expert Opin Drug Deliv"},{"key":"1626_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","volume":"17","author":"C Le Bourlais","year":"1998","unstructured":"Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems recent advances. Prog Retin Eye Res. 1998;17:33\u201358.","journal-title":"Prog Retin Eye Res"},{"key":"1626_CR3","first-page":"4423","volume":"2231","author":"A Mishra","year":"2011","unstructured":"Mishra A, Kapoor A, Bhargava S. Proniosomal gel as a carrier for improved transdermal drug-delivery. Asian J Pharm Clin Res. 2011;2231:4423.","journal-title":"Asian J Pharm Clin Res"},{"key":"1626_CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.328.7431.97","volume":"328","author":"P Khaw","year":"2004","unstructured":"Khaw P, Shah P, Elkington A. ABC of eyes: glaucoma\u20141: diagnosis. BMJ. 2004;328:97.","journal-title":"BMJ."},{"key":"1626_CR5","first-page":"18","volume":"82","author":"N Schellack","year":"2015","unstructured":"Schellack N, Bezuidenhout S. Glaucoma: a brief review. SA Pharm J. 2015;82:18\u201322.","journal-title":"SA Pharm J"},{"key":"1626_CR6","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/10717544.2018.1477861","volume":"25","author":"NH Fouda","year":"2018","unstructured":"Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2018;25:1340\u20139.","journal-title":"Drug Deliv"},{"key":"1626_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5530\/phm.2018.2.13","volume":"9","author":"PA Shah","year":"2018","unstructured":"Shah PA, Gevariya NR, Christian JR, Patel KG, Thakkar VT, Gohel MC, et al. Science based development of viscous eye drop of dorzolamide hydrochloride and timolol maleate using full factorial design. Pharm Methods. 2018;9:69\u201378.","journal-title":"Pharm Methods"},{"key":"1626_CR8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Jwala J, Boddu SH, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res. 2009;26:1197.","journal-title":"Pharm Res"},{"key":"1626_CR9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/eye.2011.82","volume":"25","author":"E Lavik","year":"2011","unstructured":"Lavik E, Kuehn M, Kwon Y. Novel drug delivery systems for glaucoma. Eye. 2011;25:578.","journal-title":"Eye."},{"key":"1626_CR10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3109\/03639041003801885","volume":"36","author":"H Ammar","year":"2010","unstructured":"Ammar H, Salama H, Ghorab M, Mahmoud A. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm. 2010;36:1330\u20139.","journal-title":"Drug Dev Ind Pharm"},{"key":"1626_CR11","unstructured":"El-Salamounia NS, Farida RM Recent drug delivery systems for treatment of glaucoma www.smgebooks.com."},{"key":"1626_CR12","first-page":"1","volume":"9","author":"IS Kurniawansyah","year":"2018","unstructured":"Kurniawansyah IS, Sopyan I, Aditya WA, Nuraini H, Alminda FD, Nurlatifah A. Preformed gel vs in situ gel: a review. Int Res J Pharm. 2018;9:1\u20135.","journal-title":"Int Res J Pharm"},{"key":"1626_CR13","first-page":"76","volume":"15","author":"K Sarada","year":"2014","unstructured":"Sarada K, Firoz S, Padmini K. In-situ gelling system: a review. Int J Curr Pharma Rev Res. 2014;15:76\u201390.","journal-title":"Int J Curr Pharma Rev Res"},{"key":"1626_CR14","first-page":"189","volume":"2","author":"KYD Yadav","year":"2010","unstructured":"Yadav KYD, Saroha K, Nanda S, Mathur P. Proniosomal gel: a provesicular approach for transdermal drug delivery. Pharm Lett. 2010;2:189\u201398.","journal-title":"Pharm Lett"},{"key":"1626_CR15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.2042-7158.1991.tb06657.x","volume":"43","author":"S Perrett","year":"1991","unstructured":"Perrett S, Golding M, Williams WP. A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes. J Pharm Pharmacol. 1991;43:154\u201361.","journal-title":"J Pharm Pharmacol"},{"key":"1626_CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2011.10.043","volume":"422","author":"MH Aburahma","year":"2012","unstructured":"Aburahma MH, Abdelbary GA. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro\/in vivo evaluation. Int J Pharm. 2012;422:139\u201350.","journal-title":"Int J Pharm"},{"key":"1626_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-5173(01)00810-9","volume":"228","author":"R Agarwal","year":"2001","unstructured":"Agarwal R, Katare O, Vyas S. Preparation and in vitro evaluation of liposomal\/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 2001;228:43\u201352.","journal-title":"Int J Pharm"},{"key":"1626_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10973-011-1299-x","volume":"108","author":"NR Pani","year":"2011","unstructured":"Pani NR, Nath LK, Acharya S, Bhuniya B. Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients. J Therm Anal Calorim. 2011;108:219\u201326.","journal-title":"J Therm Anal Calorim"},{"key":"1626_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2008.01.056","volume":"357","author":"A Abd-Elbary","year":"2008","unstructured":"Abd-Elbary A, El-Laithy H, Tadros M. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm. 2008;357:189\u201398.","journal-title":"Int J Pharm"},{"key":"1626_CR20","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.2147\/IJN.S150366","volume":"12","author":"I Elsayed","year":"2017","unstructured":"Elsayed I, Sayed S. Tailored nanostructured platforms for boosting transcorneal permeation: Box\u2013Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization. Int J Nanomedicine. 2017;12:7947\u201362.","journal-title":"Int J Nanomedicine"},{"key":"1626_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2018.08.001","volume":"549","author":"S Sayed","year":"2018","unstructured":"Sayed S, Elsayed I, Ismail MM. Optimization of \u03b2-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug. Int J Pharm. 2018;549:249\u201360.","journal-title":"Int J Pharm"},{"key":"1626_CR22","first-page":"191","volume":"4","author":"H Priyanka","year":"2015","unstructured":"Priyanka H, Bhaskar NV, Prashanthi Priya SP, Ravi Shankar V. Formulation and evaluation of carvedilol proniosomal gel. Int J Pharm Pharm Sci. 2015;4:191\u2013202.","journal-title":"Int J Pharm Pharm Sci"},{"key":"1626_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0168-3659(94)90012-4","volume":"31","author":"C Volland","year":"1994","unstructured":"Volland C, Wolff M, Kissel T. The influence of terminal gamma-sterilization on captopril containing poly (D, L-lactide-co-glycolide) microspheres. J Control Release. 1994;31:293\u2013305.","journal-title":"J Control Release"},{"key":"1626_CR24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejpb.2004.09.012","volume":"59","author":"W Weyenberg","year":"2005","unstructured":"Weyenberg W, Vermeire A, Vandervoort J, Remon JP, Ludwig A. Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets. Eur J Pharm Biopharm. 2005;59:527\u201336.","journal-title":"Eur J Pharm Biopharm"},{"key":"1626_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(97)00100-4","volume":"54","author":"B Vora","year":"1998","unstructured":"Vora B, Khopade AJ, Jain N. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release. 1998;54:149\u201365.","journal-title":"J Control Release"},{"key":"1626_CR26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jddst.2016.03.014","volume":"33","author":"GA Abdelbary","year":"2016","unstructured":"Abdelbary GA, Amin MM, Abdelmoteleb M. Novel mixed hydrotropic solubilization of Zaleplon: formulation of oral tablets and in-vivo neuropharmacological characterization by monitoring plasma GABA level. J Drug Deliv Sci Tec. 2016;33:98\u2013113.","journal-title":"J Drug Deliv Sci Tec"},{"key":"1626_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10717544.2016.1247928","volume":"24","author":"GA Abdelbary","year":"2017","unstructured":"Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24:309\u201319.","journal-title":"Drug Deliv"},{"key":"1626_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","volume":"1","author":"GP Kumar","year":"2011","unstructured":"Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery an overview. Acta Pharm Sin B. 2011;1:208\u201319.","journal-title":"Acta Pharm Sin B"},{"key":"1626_CR29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0167-7799(00)01485-2","volume":"18","author":"SM Moghimi","year":"2000","unstructured":"Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 2000;18:412\u201320.","journal-title":"Trends Biotechnol"},{"key":"1626_CR30","doi-asserted-by":"crossref","first-page":"49463","DOI":"10.1039\/C7RA07834J","volume":"7","author":"MH Nematollahi","year":"2017","unstructured":"Nematollahi MH, Pardakhty A, Torkzadeh-Mahanai M, Mehrabani M, Asadikaram G. Changes in physical and chemical properties of niosome membrane induced by cholesterol: a promising approach for niosome bilayer intervention. RSC Adv. 2017;7:49463\u201372.","journal-title":"RSC Adv"},{"key":"1626_CR31","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3109\/10717544.2015.1116027","volume":"23","author":"R Rajabalaya","year":"2016","unstructured":"Rajabalaya R, David SR, Chellian J, Xin Yun G, Chakravarthi S. Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder. Drug Deliv. 2016;23:1578\u201387.","journal-title":"Drug Deliv"},{"key":"1626_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(02)00301-0","volume":"244","author":"Y Hao","year":"2002","unstructured":"Hao Y, Zhao F, Li N, Yang Y. Li Ka. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm. 2002;244:73\u201380.","journal-title":"Int J Pharm"},{"issue":"11","key":"1626_CR33","first-page":"19","volume":"11","author":"K Ruckmani","year":"2010","unstructured":"Ruckmani K. SV. Formulation and optimization of Zidovudine niosomes. AAPS PharmSciTech. 2010;11(11):19\u201327.","journal-title":"AAPS PharmSciTech"},{"key":"1626_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0378-5173(00)00362-8","volume":"201","author":"P Arunothayanun","year":"2000","unstructured":"Arunothayanun P, Bernard M-S, Craig D, Uchegbu I, Florence A. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm. 2000;201:7\u201314.","journal-title":"Int J Pharm"},{"key":"1626_CR35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0927-7765(03)00080-8","volume":"30","author":"A Manosroi","year":"2003","unstructured":"Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B: Biointerfaces. 2003;30:129\u201338.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1626_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","volume":"172","author":"IFVS Uchegbu","year":"1998","unstructured":"Uchegbu IFVS. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33\u201370.","journal-title":"Int J Pharm"},{"key":"1626_CR37","first-page":"103","volume":"23","author":"KSV Ruckmani","year":"2010","unstructured":"Ruckmani KSV, Durga S, Jailani S. Pak. Proniosomes as drug carriers. J Pharm Sci. 2010;23:103\u20137.","journal-title":"J Pharm Sci"},{"key":"1626_CR38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","volume":"9","author":"G Abdelbary","year":"2008","unstructured":"Abdelbary G, El-gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9:740\u20137.","journal-title":"AAPS PharmSciTech"},{"key":"1626_CR39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/08982104.2014.941861","volume":"25","author":"GA Abdelbary","year":"2015","unstructured":"Abdelbary GA, Aburahma MH. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. J Liposome. 2015;25:107\u201321.","journal-title":"J Liposome"},{"key":"1626_CR40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/s12249-013-0034-2","volume":"15","author":"T Madheswaran","year":"2014","unstructured":"Madheswaran T, Baskaran R, Yong CS, Yoo BK. Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. AAPS PharmSciTech. 2014;15:44\u201351.","journal-title":"AAPS PharmSciTech"},{"key":"1626_CR41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/03639045.2012.687745","volume":"39","author":"M Bandivadekar","year":"2013","unstructured":"Bandivadekar M, Pancholi S, Kaul-Ghanekar R, Choudhari A, Koppikar S. Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study. Drug Dev Ind Pharm. 2013;39:696\u2013703.","journal-title":"Drug Dev Ind Pharm"},{"key":"1626_CR42","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1208\/pt070491","volume":"7","author":"PV Pople","year":"2006","unstructured":"Pople PV, Singh KK. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech. 2006;7:E63\u20139.","journal-title":"AAPS PharmSciTech"},{"key":"1626_CR43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2007.03.011","volume":"340","author":"M Kassem","year":"2007","unstructured":"Kassem M, Rahman AA, Ghorab M, Ahmed M, Khalil R. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm. 2007;340:126\u201333.","journal-title":"Int J Pharm"},{"key":"1626_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)90228-3","volume":"105","author":"T Yoshioka","year":"1994","unstructured":"Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994;105:1\u20136.","journal-title":"Int J Pharm"},{"key":"1626_CR45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(97)00294-9","volume":"160","author":"M Carafa","year":"1998","unstructured":"Carafa M, Santucci E, Alhaique F, Coviello T, Murtas E, Riccieri F, et al. Preparation and properties of new unilamellar non-ionic\/ionic surfactant vesicles. Int J Pharm. 1998;160:51\u20139.","journal-title":"Int J Pharm"},{"key":"1626_CR46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/1735-5362.213979","volume":"12","author":"S Shaker","year":"2017","unstructured":"Shaker S, Gardouh AR, Ghorab MM. Factors affecting liposomes particle size prepared by ethanol injection method. Res Pharm Sci. 2017;12:346.","journal-title":"Res Pharm Sci"},{"key":"1626_CR47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3109\/10837450.2013.829095","volume":"19","author":"AA Hasan","year":"2014","unstructured":"Hasan AA. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride. Pharm Dev Technol. 2014;19:748\u201354.","journal-title":"Pharm Dev Technol"},{"key":"1626_CR48","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jpba.2008.08.028","volume":"48","author":"A Sz\u0171ts","year":"2008","unstructured":"Sz\u0171ts A, Makai Z, Rajk\u00f3 R, Szab\u00f3-R\u00e9v\u00e9sz P. Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release. J Pharm Biomed Anal. 2008;48:1136\u201342.","journal-title":"J Pharm Biomed Anal"},{"key":"1626_CR49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.03.008","volume":"391","author":"EB Basalious","year":"2010","unstructured":"Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 2010;391:203\u201311.","journal-title":"Int J Pharm"},{"key":"1626_CR50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","volume":"16","author":"A Zimmer","year":"1995","unstructured":"Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev. 1995;16:61\u201373.","journal-title":"Adv Drug Deliv Rev"},{"key":"1626_CR51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.colsurfb.2010.07.029","volume":"81","author":"E Gonzalez-Mira","year":"2010","unstructured":"Gonzalez-Mira E, Egea M, Garcia M, Souto E. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B: Biointerfaces. 2010;81:412\u201321.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1626_CR52","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/03639049009104410","volume":"16","author":"S Botha","year":"1990","unstructured":"Botha S, L\u00f6tter A. Compatibility study between naproxen and tablet excipients using differential scanning calorimetry. Drug Dev Ind Pharm. 1990;16:673\u201383.","journal-title":"Drug Dev Ind Pharm"},{"key":"1626_CR53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2012.09.028","volume":"64","author":"J Siepmann","year":"2012","unstructured":"Siepmann J, Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2012;64:163\u201374.","journal-title":"Adv Drug Deliv Rev"},{"key":"1626_CR54","first-page":"33","volume":"1","author":"SAD Gupta","year":"2009","unstructured":"Gupta SAD, Sharma NK, Jhade D. Proniosomal gel as a carrier for improved transdermal delivery of Griseofulvin: preparation and in-vitro characterization. Res J Pharm Dos Tech. 2009;1:33\u20137.","journal-title":"Res J Pharm Dos Tech"},{"key":"1626_CR55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/10611860902963039","volume":"17","author":"RKAM Thakur","year":"2009","unstructured":"Thakur RKAM, Shams MS, Ali A, Khar RK. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation. J Drug Target. 2009;17:442\u20139.","journal-title":"J Drug Target"},{"key":"1626_CR56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/js980343j","volume":"88","author":"S Murdan","year":"1999","unstructured":"Murdan S, van den Bergh B, Gregoriadis G, Florence AT. Water in sorbitan monosterate organo gels (water in oil gels). J Pharm Sci. 1999;88:615\u20139.","journal-title":"J Pharm Sci"},{"key":"1626_CR57","first-page":"265","volume":"31","author":"PO-P Gobindpura","year":"2015","unstructured":"Gobindpura PO-P. Ludhiana, Punjab, India. Design, development and evaluation of proniosomal gel of an antifungal drug - ketoconazole. Int J Pharm Sci Rev Res. 2015;31:265\u201372.","journal-title":"Int J Pharm Sci Rev Res"},{"key":"1626_CR58","first-page":"685","volume":"24","author":"N Van Abbe","year":"1973","unstructured":"Van Abbe N. Eye irritation: studies relating to responses in man and laboratory animals. J Cosmet Sci. 1973;24:685\u201392.","journal-title":"J Cosmet Sci"},{"key":"1626_CR59","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","volume":"513","author":"AA Abdelbary","year":"2016","unstructured":"Abdelbary AA, Abd-Elsalam WH, Al-mahallawi AM. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment. Int J Pharm. 2016;513:688\u201396.","journal-title":"Int J Pharm"},{"key":"1626_CR60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2015.07.010","volume":"492","author":"AH Salama","year":"2015","unstructured":"Salama AH, Shamma RN. Tri\/tetra-block co-polymeric nanocarriers as a potential ocular delivery system of lornoxicam: in-vitro characterization, and in-vivo estimation of corneal permeation. Int J Pharm. 2015;492:28\u201339.","journal-title":"Int J Pharm"},{"key":"1626_CR61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ICU.0000000000000031","volume":"25","author":"JK O\u2019rese","year":"2014","unstructured":"O\u2019rese JK, Lawrence SD. Sustained drug delivery in glaucoma. Curr Opin Ophthalmol. 2014;25:112\u20137.","journal-title":"Curr Opin Ophthalmol"},{"key":"1626_CR62","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2885.2007.00890.x","volume":"30","author":"F Gasthuys","year":"2007","unstructured":"Gasthuys F, Pockel\u00e9 K, Vervaet C, Weyenberg W, De Prijck K, Pille F, et al. Evaluation of the in vivo behaviour of gentamicin sulphate ocular mini-tablets in ponies. J Vet Pharmacol Ther. 2007;30:470\u20136.","journal-title":"J Vet Pharmacol Ther"},{"key":"1626_CR63","first-page":"942","volume":"6","author":"A Dubey","year":"2014","unstructured":"Dubey A, Prabhu P. Development and investigation of niosomes of brimonidine tartrate and timolol maleate for the treatment of glaucoma. Int J PharmTech Res. 2014;6:942\u201350.","journal-title":"Int J PharmTech Res"},{"key":"1626_CR64","first-page":"R1","volume":"61","author":"K Chandraprakash","year":"1990","unstructured":"Chandraprakash K, Udupa N, Umadevi P, Pillai G. Pharmacokinetic evaluation of surfactant vesicle-entrapped methotrexate in tumor-bearing mice. Int J Pharm Tech Res. 1990;61:R1\u20134.","journal-title":"Int J Pharm Tech Res"},{"key":"1626_CR65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1166\/jbn.2010.1101","volume":"6","author":"K Ruckmani","year":"2010","unstructured":"Ruckmani K, Sankar V, Sivakumar M. Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. J Biomed Nanotechnol. 2010;6:43\u201351.","journal-title":"J Biomed Nanotechnol"},{"key":"1626_CR66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1208\/s12248-015-9830-9","volume":"18","author":"DA Diaz","year":"2016","unstructured":"Diaz DA, Colgan ST, Langer CS, Bandi NT, Likar MD, Van Alstine L. Dissolution similarity requirements: how similar or dissimilar are the global regulatory expectations? The AAPS J. 2016;18:15\u201322.","journal-title":"The AAPS J"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-1626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-020-1626-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-1626-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T19:31:40Z","timestamp":1612207900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-020-1626-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-1626-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocol was confirmed by Research Ethics Committee, Faculty of Pharmacy, Cairo University (REC-FOPCU) with a number of PI 2134. This study was approved by \u201cAnimal Care and Use Committee, Faculty of Pharmacy, Cairo University\u201d (PI 2134).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"87"}}